SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question, Lancet Gastroenterology and Hepatology

Amongst other points, article highlights that patients with cirrhosis are likely to have attenuated immune responses with vaccination. Nonetheless, given the high COVID-19-related mortality in these patients, it remains important to prioritise vaccination in this subgroup.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news